Home > Project Types > CEA/CUA > Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA

Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA

Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA

 

 

Early versus delayed use of Sofosbuvir plus Peginterferon/Ribavirin therapy in fibrosis patients with hepatitis C virus: A cost-effectiveness analysis
50th International Liver Congress (EASL). Vienna, Austria. 22- 26 apr 2015